The composite packs in four different dosage strengths are predicted to be in shortage in Australia until end of January
Atozet tablets, used for hypercholesterolaemia, are currently experiencing a shortage.
- Atozet ezetimibe/atorvastatin 10mg/40mg tablet blister pack (From 30 Oct 2017 to 31 Jan 2018)
- Atozet ezetimibe/atorvastatin 10mg/80mg tablet blister pack (From 30 Nov 2017 to 31 Jan 2018)
- Atozet ezetimibe/atorvastatin 10mg/20mg tablet blister pack (From 30 Nov 2017 to 31 Jan 2018)
- Atozet ezetimibe/atorvastatin 10mg/10mg tablet blister pack (From 30 Nov 2017 to 31 Jan 2018)
MSD Australia says there is currently a global shortage due to manufacturing isuses.
The group says the shortage is not related to any quality issues.
Contact MSD for more information on (02) 8988 8000.
Arrow Pharma’s glyceryl trinitrate 600microgram tablet bottles are also in shortage, with its Anginine and Lycinate lines expected to become available on 27 February 2018.
Two of Pfizer’s methotrexate injection vials are unavailable until the end of the year: the 5mg/2mL and the 50mg/2mL.
And Pfizer’s Lignocaine 2% gel syringe is also experiencing a shortage, expected to be resolved in June next year.
However the shortage of its Lignocaine 2% with Chlorhexidine 0.05% gel syringe should be resolved by end of February.
Anticipated shortages for the coming months include the following medicines (among others):
Keep an eye on the Medicines Shortage Information Initiative for further updates.